Back
Cadrenal Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
17
CVKD
Cadrenal Therapeutics, Inc.
Last Price:
$4.74
Seasonality Move:
-11.48%
7 Day Trial
ALL ACCESS PASS
$
7
Cadrenal Therapeutics, Inc. Stock Forecast
-
Is Cadrenal Therapeutics, Inc. Stock Undervalued?The current Cadrenal Therapeutics, Inc. [CVKD] share price is $4.70. The Score for CVKD is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
-
CVKD is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Cadrenal Therapeutics, Inc. Stock Go Up Next Year?
Data Unavailable
Cadrenal Therapeutics, Inc. Stock Rating
Data Unavailable
Cadrenal Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
cadrenal.com
52-Week Data
52-Week High:
17.97
52-Week Low:
4.21
Prediction Charts
Market Cap:
10.6M
Price in USD:
4.70
Volume:
13.6K
Beta:
1.49
Technical Analysis
SMA50:
6.72
SMA100:
7.97
SMA200:
10.29
52-Wk Change:
-73.4%
Stock Predictions
-
Is Cadrenal Therapeutics, Inc. stock public?Yes, Cadrenal Therapeutics, Inc. is a publicly traded company.
-
What is the Cadrenal Therapeutics, Inc. stock quote today?The Cadrenal Therapeutics, Inc. stock price is 4.70 USD today.
-
How to buy Cadrenal Therapeutics, Inc. stock online?You can buy Cadrenal Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-16 | 7.43 | 7.53 | 7.87 | 7.43 |
| Mar-17 | 7.65 | 7.54 | 7.92 | 7.53 |
| Mar-18 | 7.50 | 7.24 | 7.66 | 7.00 |
| Mar-19 | 7.07 | 6.97 | 7.22 | 6.83 |
| Mar-20 | 6.84 | 6.52 | 7.11 | 6.40 |
| Mar-23 | 6.45 | 6.15 | 6.85 | 6.10 |
| Mar-24 | 6.03 | 5.73 | 6.44 | 5.49 |
| Mar-25 | 5.74 | 5.42 | 5.74 | 4.94 |
| Mar-26 | 5.26 | 5.24 | 5.94 | 5.22 |
| Mar-27 | 5.40 | 4.99 | 5.54 | 4.91 |
| Mar-30 | 4.99 | 4.25 | 5.05 | 4.21 |
| Mar-31 | 4.33 | 5.12 | 5.19 | 4.32 |
| Apr-1 | 5.14 | 4.90 | 5.50 | 4.37 |
| Apr-2 | 4.71 | 4.70 | 4.81 | 4.54 |
Cadrenal Therapeutics, Inc. Earnings
Data Unavailable
Cadrenal Therapeutics, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.55 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.37 per share, and an increase next year of $1.87 per share.
* Cadrenal Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.